Clinical Trials Browser

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

NCT07143669 2026-03-10

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Recruiting

450 enrolled

MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

NCT06186856 2026-03-05

DATAMAST

Recruiting

13,000 enrolled

Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT05186753 2026-03-04

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Phase 2 Active not recruiting

237 enrolled

Myeloid

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Mastocytosis, Mastocytosis, Systemic

NCT07255638 2026-02-10

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Recruiting

80 enrolled

Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT00044122 2026-01-08

Study of Factors Regulating Mast Cell Proliferation

Recruiting

600 enrolled

Myeloid

Mastocytosis

NCT00255346 2025-12-30

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Phase 2 Completed

68 enrolled 13 charts

MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Primary Myelofibrosis

NCT07264959 2025-12-04

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Not yet recruiting

150 enrolled

Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT05323188 2025-09-12

KID-Tryp

Completed

402 enrolled

Myeloid

Mast Cell Activation Syndrome, Mastocytosis

NCT04996875 2025-05-30

APEX

Phase 2 Recruiting

140 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

Clinical Trials

EGR2

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

DATAMAST

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Study of Factors Regulating Mast Cell Proliferation

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

KID-Tryp

APEX